Logo Image
News
Media
PodcastsCase Based Peer PerspectivesClinical Forum InsightsInsightsInvestigator PerspectivesMedical World NewsPeer ExchangePeers & PerspectivesShortsSpecial ReportVideos
Conferences
Conference CoverageConference Listing
Publications
Contemporary OB/GYN® JournalDigital Supplements
More
CME/CE
Resources
Physician Fact SheetsInteractive ToolsSponsored MediaSponsored ResourcesSupplements and Featured Publications
About
Partnerships

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • About
  • Partnerships
  • Breast Health
  • COVID-19
  • Cervical Health
  • Contraception
  • Curbside Consults
  • Dermatology
  • Drug Pipeline News
  • Endometriosis
  • Genetic Testing
  • Gynecology
    • Gynecologic Oncology
  • Imaging
    • Fetal Imaging
    • Abnormal Obstetrical Ultrasound
    • MRI
    • Ultrasound
    • Women's Imaging
    • Breast Imaging
    • Women's Ultrasound
  • Infertility
  • LARC
  • Legally Speaking
  • Life Transitions
  • Malpractice
  • Menopause
  • Mental Health
  • Noninvasive Prenatal Testing
  • Obstetrics
  • Opinion
  • Osteoporosis
  • Pediatrics
  • Practice Management
  • Pregnancy and Birth
  • Sexual Health
  • Sexually Transmitted Infections
  • Surgery
  • Technology
  • Urology
  • Uterine Fibroids
  • Vulvovaginal Disease
  • Well Woman
Advertisement

Heidi Anne Duerr

Advertisement

Articles by Heidi Anne Duerr

Do Medications for Urinary Incontinence Cause More Harm Than Good?

ByHeidi Anne Duerr
April 18th 2012

Urinary incontinence plagues as many as 17% of women in the United States. Some medications claim to ease the disease burden, but how well do these medications work?

Advertisement

Latest Updated Articles

  • Do Medications for Urinary Incontinence Cause More Harm Than Good?
    Do Medications for Urinary Incontinence Cause More Harm Than Good?

    April 18th 2012



Advertisement
Advertisement

Trending on Contemporary OB/GYN

1

Society of Family Planning issues first guidance on deep and nonpalpable contraceptive implant removal

2

Phase 3 LUNA study: atogepant reduces menstrual migraine days vs. placebo

3

Certolizumab pegol receives FDA BTD for adverse pregnancy outcomes in APS

4

PMOS Awareness Month: Watch our expert panel discussion on PMOS

5

ACOG's 2026-27 respiratory vaccine guidance, estradiol patch supply update, and more

  • Advertise
  • Contact Us
  • Job Board
  • Terms of Use
  • Privacy Policy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us